MERIT CRO公司和Mianus Capital基金今天宣布新成立一个由眼科领域中最负盛名的创新企业家、临床医生与科学家组成的联合科学顾问委员会 (SAC)。
眼科科学顾问委员会将为 MERIT CRO 公司和 Mianus Capital 基金提供尖端生物科技技术和治疗方案的咨询，帮助二家公司为符合市场与病人的需求提供优质完备的临床试验服务与投资，推动生命科学创新来改善全球眼科疾病患者的治疗。
We are proud to work with this prestigious group of industry leaders that provoides unparalleled experience in both clinical research and innovation.
MERIT CRO公司的创始人与CEO黄一骏博士表示：“我们很荣幸能够与这个享有盛誉的行业领军团队合作，他们在临床研究和技术创新拥有无与伦比的丰富经验。我们的合作将为改善人们的视力和生活质量带来更多的医疗创新与突破。”
Having been built by insiders of the drug development ecosystem, our CRO+VC platform offers deep access to KOLs and PIs who are at the forefront of biotech innovation.
Mianus Capital 创始人兼首席执行官 Steve Yang 表示:"作为医药研发生态圈的内部组成，我们的 CRO+VC 平台有得天独厚的条件与生物技术创新前沿的 KOL 和 PI 专家们进行深度地交流, 正是这种深度交流为我们提供了眼科、制药和生物技术行业的透彻认知与独特见解，支持我们在生命科学领域中的早期投资，这将推进更多变革性的新技术和治疗方法的应用"
Mianus Clarity Fund
2023年4月Mianus Captal 和 MERIT CRO 在美国视觉和眼科研究协会 (ARVO) 2023 年会上宣布联合推出首期 Mianus Clarity Fund 风投基金致力于推动眼科创新。
我们认为由于全球人口老龄化、大量未满足的医疗需求、有希望的突破性技术、强大的进入壁垒以及创新产品的有利退出机会，眼科是一个具有巨大投资机会的细分领域。
新成立的眼科科学顾问委员会 (SAC)由多位眼科领域中最优秀的创新企业家、临床医生和科学家组成：
Robert Avery, MD
California Retina Consultants, Santa Barbara, California. Founding Partner, Director of Clinical Research, Appointment in the Neuroscience Research Institute; University of California, Santa Barbara, Founder of the California Retina Research Foundation.
David S. Boyer, MD
Retina Vitreous Associates Medical Group, Beverly Hills, California. Senior Partner, Clinical Faculty at the Doheny Eye Institute, USC School of Medicine.
David Brown, MD
Retina Consultants of Texas, Houston, Texas. Founding Partner, Director of Clinical Research, Director of the Greater Houston Retina Research Center, Clinical Professor of Ophthalmology at Baylor College of Medicine, Vice-Chair for Research; Blanton Eye Institute at Houston Methodist Hospital.
Antonio Capone Jr., MD
Associated Retina Consultants, Royal Oak, Michigan. Professor of Biomedical Sciences at Oakland University, and Professor at the European School for Advanced Studies in Ophthalmology, Lugano, Switzerland, Co-Director of the Vision Research-ROPARD Foundation, Co-Director of the Associated Retinal Consultants Vitreoretinal Fellowship Training Program.
Mark S. Humayun, MD, PhD
USC Roski Eye Institute, Los Angelas, California. University Professor of Ophthalmology, Cornelius J. Pings Chair in Biomedical Sciences, Director, Institute for Biomedical Therapeutics, Co-Director USC Roski Eye Institute.
Arshad M. Khanani, MD, MA, FASRS
Sierra Eye Associates, Reno, Nevada. Managing Partner, Director of Clinical Research, Director of Fellowship, Clinical Associate Professor, University of Nevada Reno School of Medicine, Reno, Nevada.
Theodore Leng, MD
Stanford University Medical Center, Palo Alto, California. Associate Professor of Ophthalmology, Director of Clinical and Translational Research, Director of Ophthalmic Diagnostics.
Richard Lindstrom, MD
Minnesota Eye Consultants, Minneapolis, Minnesota. Founding Partner, Adjunct Professor Emeritus at the University of Minnesota Department of Ophthalmology.
Carl D. Regillo, MD, FACS, FASRS
Will Eye Hospital, Bryn Mawr, Pennsylvania. Director of the Retina Service; Wills Eye Hospital, Professor of Ophthalmology at Thomas Jefferson University in Philadelphia.
Charles C. Wykoff, MD., PhD
Retina Consultants of Texas, Houston, Texas. Director of the Retina Consultants of Texas Research Centers, Chairman of the Research and Clinical Trials Committee.
另外还有Sadda博士作为眼科风投基金的顾问提供咨询：
SriniVas R. Sadda, MD
Doheny Eye Institute/ Stein Eye Institute, Pasadena, California. President & Chief Scientific Officer, Stephen J. Ryan-Arnold and Mabel Beckman Foundation Endowed Presidential Chair (Advisor only to Mianus Capital)
联系我们,了解我们如何运用专业的知识和方法帮助您在预算内准时将产品推向市场。您的成功是我们的首要任务。
